Medtronic (0Y6X) Ratios
Medtronic Ratios
GB:0Y6X's free cash flow for Q1 2027 was $1.29B. For the 2027 fiscal year, GB:0Y6X's free cash flow was decreased by $-503.00M and operating cash flow was $1.79B. See a summary of the company’s cash flow.
| Ratios | Apr 26 | Apr 25 | Apr 24 | Apr 23 | Apr 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.13 | 1.85 | 2.03 | 2.39 | 1.86 |
| Quick Ratio | 1.62 | 1.42 | 1.55 | 1.81 | 1.49 |
| Cash Ratio | 0.17 | 0.17 | 0.12 | 0.17 | 0.30 |
| Solvency Ratio | 0.18 | 0.17 | 0.16 | 0.16 | 0.20 |
| Operating Cash Flow Ratio | 0.63 | 0.55 | 0.63 | 0.67 | 0.59 |
| Short-Term Operating Cash Flow Coverage | 4.11 | 2.46 | 6.25 | 464.54 | 1.97 |
| Net Current Asset Value | $ -18.17B | $ -19.61B | $ -17.63B | $ -17.61B | $ -15.20B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.31 | 0.28 | 0.27 | 0.27 |
| Debt-to-Equity Ratio | 0.57 | 0.59 | 0.50 | 0.47 | 0.46 |
| Debt-to-Capital Ratio | 0.36 | 0.37 | 0.33 | 0.32 | 0.31 |
| Long-Term Debt-to-Capital Ratio | 0.35 | 0.35 | 0.32 | 0.32 | 0.28 |
| Financial Leverage Ratio | 1.88 | 1.91 | 1.79 | 1.77 | 1.73 |
| Debt Service Coverage Ratio | 3.41 | 2.30 | 3.92 | 10.97 | 1.94 |
| Interest Coverage Ratio | 9.04 | 8.17 | 7.15 | 8.62 | 10.40 |
| Debt to Market Cap | 0.26 | 0.26 | 0.23 | 0.20 | 0.17 |
| Interest Debt Per Share | 22.37 | 22.75 | 19.39 | 18.80 | 18.38 |
| Net Debt to EBITDA | 2.65 | 2.85 | 2.89 | 2.62 | 2.32 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.02% | 65.32% | 65.34% | 65.67% | 67.98% |
| EBIT Margin | 18.84% | 18.96% | 17.17% | 19.21% | 19.16% |
| EBITDA Margin | 26.97% | 27.49% | 25.35% | 27.85% | 27.70% |
| Operating Profit Margin | 17.78% | 17.76% | 15.89% | 17.56% | 18.15% |
| Pretax Profit Margin | 16.87% | 16.78% | 14.95% | 17.18% | 17.41% |
| Net Profit Margin | 13.20% | 13.90% | 11.36% | 12.03% | 15.90% |
| Continuous Operations Profit Margin | 13.30% | 13.99% | 11.44% | 12.12% | 15.97% |
| Net Income Per EBT | 78.23% | 82.84% | 76.00% | 70.06% | 91.34% |
| EBT Per EBIT | 94.88% | 94.51% | 94.03% | 97.79% | 95.91% |
| Return on Assets (ROA) | 5.16% | 5.09% | 4.09% | 4.13% | 5.54% |
| Return on Equity (ROE) | 9.70% | 9.71% | 7.32% | 7.30% | 9.59% |
| Return on Capital Employed (ROCE) | 7.95% | 7.56% | 6.50% | 6.70% | 7.32% |
| Return on Invested Capital (ROIC) | 6.13% | 6.08% | 4.91% | 4.72% | 6.41% |
| Return on Tangible Assets | 11.91% | 12.18% | 10.28% | 10.84% | 14.44% |
| Earnings Yield | 4.49% | 4.31% | 3.45% | 3.12% | 3.60% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.47 | 5.15 | 5.28 | 5.21 | 5.71 |
| Payables Turnover | 4.81 | 4.75 | 4.65 | 4.03 | 4.46 |
| Inventory Turnover | 2.14 | 2.12 | 2.15 | 2.03 | 2.20 |
| Fixed Asset Turnover | 4.90 | 4.91 | 5.28 | 5.61 | 5.85 |
| Asset Turnover | 0.39 | 0.37 | 0.36 | 0.34 | 0.35 |
| Working Capital Turnover Ratio | 3.02 | 3.04 | 2.72 | 2.68 | 2.57 |
| Cash Conversion Cycle | 161.57 | 165.89 | 160.46 | 159.70 | 148.13 |
| Days of Sales Outstanding | 66.68 | 70.91 | 69.11 | 70.11 | 63.94 |
| Days of Inventory Outstanding | 170.75 | 171.83 | 169.78 | 180.24 | 166.08 |
| Days of Payables Outstanding | 75.86 | 76.85 | 78.43 | 90.65 | 81.89 |
| Operating Cycle | 237.43 | 242.74 | 238.89 | 250.34 | 230.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.72 | 5.48 | 5.11 | 4.54 | 5.47 |
| Free Cash Flow Per Share | 4.23 | 4.03 | 3.92 | 3.44 | 4.45 |
| Dividend Paid and CapEx Coverage Ratio | 1.32 | 1.29 | 1.29 | 1.19 | 1.55 |
| Capital Expenditure Coverage Ratio | 3.85 | 3.79 | 4.28 | 4.14 | 5.37 |
| Operating Cash Flow Coverage Ratio | 0.26 | 0.25 | 0.27 | 0.25 | 0.30 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.21 | 0.21 | 0.19 | 0.23 |
| Free Cash Flow Yield | 5.08% | 4.79% | 4.88% | 3.80% | 4.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 22.22 | 23.18 | 28.98 | 32.09 | 27.80 |
| Price-to-Sales (P/S) Ratio | 2.94 | 3.23 | 3.29 | 3.86 | 4.42 |
| Price-to-Book (P/B) Ratio | 2.16 | 2.25 | 2.12 | 2.34 | 2.67 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 19.68 | 20.87 | 20.49 | 26.33 | 23.43 |
| Price-to-Operating Cash Flow Ratio | 14.57 | 15.36 | 15.70 | 19.97 | 19.07 |
| Price-to-Earnings Growth (PEG) Ratio | 6.72 | 0.75 | -13.67 | -1.31 | 0.70 |
| Enterprise Value Multiple | 13.54 | 14.59 | 15.88 | 16.49 | 18.29 |
| Enterprise Value | 132.81B | 134.49B | 130.27B | 143.41B | 160.49B |
| EV to EBITDA | 13.54 | 14.59 | 15.88 | 16.49 | 18.29 |
| EV to Sales | 3.65 | 4.01 | 4.03 | 4.59 | 5.07 |
| EV to Free Cash Flow | 24.48 | 25.94 | 25.05 | 31.31 | 26.85 |
| EV to Operating Cash Flow | 18.12 | 19.09 | 19.19 | 23.75 | 21.85 |
| Tangible Book Value Per Share | -2.08 | -4.00 | -2.86 | -3.46 | -2.51 |
| Shareholders’ Equity Per Share | 38.59 | 37.36 | 37.82 | 38.71 | 39.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.17 | 0.23 | 0.29 | 0.08 |
| Revenue Per Share | 28.37 | 26.09 | 24.38 | 23.48 | 23.60 |
| Net Income Per Share | 3.74 | 3.63 | 2.77 | 2.83 | 3.75 |
| Tax Burden | 0.78 | 0.83 | 0.76 | 0.70 | 0.91 |
| Interest Burden | 0.90 | 0.89 | 0.87 | 0.89 | 0.91 |
| Research & Development to Revenue | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| SG&A to Revenue | 0.32 | 0.32 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.52 | 1.50 | 1.85 | 1.60 | 1.45 |
Currency in USD